[5] [6] Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
However, there have been no definitive clinical trials
For a comprehensive fat loss approach, my book 30 Days 2 Shredz covers how to integrate peptide stacks into a complete protocol alongside my best advice on training, nutrition, fasting, and all the variables that determine whether you actually get results
Yet human data remain mixed: some trials report no difference in bone-formation markers , while others find slight increases in bone resorption at the hip ([Wiley systematic review, 2024])
World Anti-Doping Agency World Anti-Doping Code International Standard Prohibited List 2025
What does the treatment look like